Kairos Pharma (KAPA) EV/EBITDA

EV/EBITDA

-4.83
+0.26+5.11%

8 min ago


Summary


Performance

KAPA EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherKAPAvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

KAPA EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+5.1%-5.2%-4.2%
1 m1 month+28.2%-28.3%-23.8%
3 m3 months+37.6%-37.7%-32.4%
6 m6 months---
ytdytd+28.9%-28.9%-24.3%
1 y1 year---
5 y5 years---

KAPA EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-monthat high-10.76+55.1%
3 m3-month-3.87-24.8%-10.76+55.1%
6 m6-month-3.87-24.8%-18.54+74.0%
1 y1-year-3.87-24.8%-18.54+74.0%
3 y3-year-3.87-24.8%-18.54+74.0%
5 y5-year-3.87-24.8%-18.54+74.0%
alltimeall time-3.87-24.8%-18.54+74.0%

Kairos Pharma EV/EBITDA History

DateValue
2025
-4.83(-28.9%)
DateValue
2024
-6.79

FAQ

  • What is Kairos Pharma EV/EBITDA?
  • What is the all time high EV/EBITDA for Kairos Pharma?
  • What is KAPA EV/EBITDA year-to-date change?

What is Kairos Pharma EV/EBITDA?

The current EV/EBITDA of KAPA is -4.83

What is the all time high EV/EBITDA for Kairos Pharma?

Kairos Pharma all-time high EV/EBITDA is -3.87

What is KAPA EV/EBITDA year-to-date change?

Kairos Pharma EV/EBITDA has changed by +1.96 (+28.87%) since the beginning of the year